In this issue:
DOACs and ASMs for AF and epilepsy: risk of thromboembolic events
Multipsychiatric comorbidity in people with vs. without epilepsy
Trends in ASM initiation, switch and termination in newly diagnosed epilepsy
Suicidality in adolescents after a diagnosis of focal epilepsy
UK’s and Norway’s views on SUDEP counselling
Perampanel according to epilepsy aetiology
First-trimester ASM use: miscarriage risk
Levetiracetam for people with and without intellectual disabilities
US trends of epilepsy-related mortality
Long-term evaluation of ANT-DBS for epilepsy
Please login below to download this issue (PDF)